Product Information
- (3S)-N-Hydroxy-2,2-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonylthiomorpholine-3-carboxamide
- (3S)-N-Hydroxy-2,2-dimethyl-4-[[4-(4-pyridinyloxy)phenyl]sulfonyl]-3-thiomorpholinecarboxamide
- (3S)-N-hydroxy-2,2-dimethyl-4-{[4-(pyridin-4-yloxy)phenyl]sulfonyl}thiomorpholine-3-carboxamide
- (S)-2,2-Dimethyl-N-Hydroxy-4-[4-(4-Pyridyloxy)Phenylsulfonyl]-1,4-Thiazinane-3-Carboxamide
- (S)-2-[(Hydroxyamino)methyl]-5,6-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonylmorpholine-3-thione
- 2-[(Hydroxyamino)Methyl]-5,6-Dimethyl-4-(4-Pyridin-4-Yloxyphenyl)Sulfonyl-Morpholine-3-Thione
- 3-Thiomorpholinecarboxamide, N-hydroxy-2,2-dimethyl-4-[[4-(4-pyridinyloxy)phenyl]sulfonyl]-, (3S)-
- 3-Thiomorpholinecarboxamide, N-hydroxy-2,2-dimethyl-4-[[4-(4-pyridinyloxy)phenyl]sulfonyl]-, (S)-
- Ag 3340
- Kb-R 9896
- See more synonyms
Prinomastat is a small molecule that inhibits the protein MCL-1. It has been shown to inhibit tumor growth in mouse xenograft models of human breast, lung, and prostate cancer. This drug also blocks the expression of matrix metalloproteinases (MMPs), which are enzymes that break down collagen and other extracellular matrix components. Prinomastat inhibits iron homeostasis and induces apoptosis in epithelial cells, suggesting a role for this drug in the treatment of bowel diseases such as Crohn's disease.
Chemical properties
Technical inquiry about: 3D-SHA32942 Prinomastat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
